Cardiovascular risk reduction with icosapent ethyl
2019
Purpose of reviewResidual risk for atherosclerotic cardiovascular disease (ASCVD) persists even among patients with optimal low-density lipoprotein cholesterol (LDL-C) levels. Randomized trials attempting to modulate other lipids beyond LDL-C have failed to demonstrate significant reductions in isch
Keywords:
- Correction
- Source
- Cite
- Save
- Machine Reading By IdeaReader
51
References
19
Citations
NaN
KQI